These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8615129)

  • 41. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.
    Liss B; Roeper J
    Brain Res Rev; 2008 Aug; 58(2):314-21. PubMed ID: 18023878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deterioration of dopaminergic pathways and alterations in cognition and motor functions.
    Dubois B; Pillon B; Agid Y
    J Neurol; 1992; 239 Suppl 1():S9-12. PubMed ID: 1634910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time sequences of dopaminergic cell death in Parkinson's disease: indications for neuroprotective studies.
    Gerlach M; Riederer PF
    Adv Neurol; 1999; 80():219-25. PubMed ID: 10410725
    [No Abstract]   [Full Text] [Related]  

  • 44. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD).
    Schmidt WJ; Alam M
    J Neural Transm Suppl; 2006; (70):273-6. PubMed ID: 17017541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
    Kress GJ; Reynolds IJ
    Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neuroplasticity and Parkinson disease].
    Viallet F; Witjas T
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S42-8. PubMed ID: 12690663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroregeneration.
    Strelau J; Unsicker K
    Adv Neurol; 2003; 91():95-100. PubMed ID: 12442667
    [No Abstract]   [Full Text] [Related]  

  • 48. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
    Lee DY; Oh YJ; Jin BK
    Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
    Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
    Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
    Steiner B; Winter C; Hosman K; Siebert E; Kempermann G; Petrus DS; Kupsch A
    Exp Neurol; 2006 Jun; 199(2):291-300. PubMed ID: 16360152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
    McRitchie DA; Cartwright HR; Halliday GM
    Exp Neurol; 1997 Mar; 144(1):202-13. PubMed ID: 9126172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the cure worse than the disease? Caveats in the move from laboratory to clinic.
    Gluckman PD; Williams CE
    Dev Med Child Neurol; 1992 Nov; 34(11):1015-8. PubMed ID: 1426679
    [No Abstract]   [Full Text] [Related]  

  • 55. [MAP-2 protein and its role in several aspects of plasticity and pathologic states in the central nervous system].
    Majewska B
    Postepy Biochem; 1995; 41(3):175-82. PubMed ID: 7491356
    [No Abstract]   [Full Text] [Related]  

  • 56. [Foxa2, a new player in the development of dopaminergic neurons in Parkinson disease].
    Epelbaum J
    Med Sci (Paris); 2008 Feb; 24(2):117. PubMed ID: 18272062
    [No Abstract]   [Full Text] [Related]  

  • 57. Parkinson's disease. The apoptosis hypothesis.
    Stern G
    Adv Neurol; 1996; 69():101-7. PubMed ID: 8615116
    [No Abstract]   [Full Text] [Related]  

  • 58. Parkinsonism-plus syndromes.
    Jankovic J
    Mov Disord; 1989; 4 Suppl 1():S95-119. PubMed ID: 2657411
    [No Abstract]   [Full Text] [Related]  

  • 59. Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases.
    Barker R
    Rev Neurosci; 1996; 7(3):187-214. PubMed ID: 8916292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival in the year 2001.
    Kater SB; Lipton SA
    Trends Neurosci; 1995 Feb; 18(2):71-2. PubMed ID: 7537415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.